Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TREK 2000 INTERNATIONAL LTD (5AB)

  • SEC News
  • April 27, 2026, 09:53 UTC
  • 0
  • 0 comments

Change - Announcement of Appointment: Appointment of Independent Non-executive Director

Comment Full text

TREK 2000 INTERNATIONAL LTD (5AB)

  • SEC News
  • April 27, 2026, 09:52 UTC
  • 0
  • 0 comments

General Announcement: Appointment of Independent Director and Changes to the Composition of the Board and Board Committees

Comment Full text

LIVINGSTONE HEALTH HOLDINGS LIMITED (PRH)

  • SEC News
  • April 27, 2026, 09:52 UTC
  • 0
  • 0 comments

General Announcement: Issue and Allotment of Shares Pursuant to Exercise of Warrants

Comment Full text

TRICKLESTAR LIMITED (CYW)

  • SEC News
  • April 27, 2026, 09:50 UTC
  • 0
  • 0 comments

Response to SGX Queries:

Comment Full text

INTRACO LIMITED (I06)

  • SEC News
  • April 27, 2026, 09:47 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: CHANGE IN INTEREST OF DIRECTOR

Comment Full text

INTRACO LIMITED (I06)

  • SEC News
  • April 27, 2026, 09:46 UTC
  • 0
  • 0 comments

General Announcement: NOTICE OF TRANSFER AND USE OF TREASURY SHARES

Comment Full text

HOE LEONG CORPORATION LTD. (H20)

  • SEC News
  • April 27, 2026, 09:42 UTC
  • 0
  • 0 comments

General Announcement: Response to questions for FY2025 Annual General Meeting

Comment Full text

MERMAID MARITIME PUBLIC CO LTD (DU4)

  • SEC News
  • April 27, 2026, 09:42 UTC
  • 0
  • 0 comments

General Announcement: Establishment of Joint Venture Company in Brunei

Comment Full text

OLAM GROUP LIMITED (VC2)

  • SEC News
  • April 27, 2026, 09:39 UTC
  • 0
  • 0 comments

Change - Announcement of Appointment: Appointment of Group Chief Financial Officer - Mr. Venkataraman Krishnan

Comment Full text

OLAM GROUP LIMITED (VC2)

  • SEC News
  • April 27, 2026, 09:38 UTC
  • 0
  • 0 comments

Change - Announcement of Cessation: Cessation of Group Chief Financial Officer - Mr. Neelamani Muthukumar

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(12073)
  • Event(5289)
  • SEC News(250783)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150139)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin